TransUnion (TRU) – Analysts’ Recent Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of TransUnion (NYSE: TRU) in the last few weeks: 8/9/2026 – TransUnion was downgraded by Wall Street Zen from “buy” to “hold”. 8/1/2026 – TransUnion was upgraded by Wall Street Zen from “hold” to “buy”. 7/30/2026 – TransUnion was downgraded by Weiss Ratings from […]
Recent Research Analysts’ Ratings Changes for Alphatec (ATEC)
Alphatec (NASDAQ: ATEC) has recently received a number of price target changes and ratings updates: 8/5/2026 – Alphatec had its price target raised by TD Cowen from $11.00 to $13.00. They now have a “buy” rating on the stock. 8/5/2026 – Alphatec had its price target raised by UBS Group AG from $15.00 to $16.00. […]
Recent Analysts’ Ratings Changes for Humana (HUM)
A number of research firms have changed their ratings and price targets for Humana (NYSE: HUM): 8/10/2026 – Humana had its price target raised by JPMorgan Chase & Co. from $316.00 to $393.00. They now have a “neutral” rating on the stock. 8/4/2026 – Humana was upgraded by Morgan Stanley from “underweight” to “equal weight”. […]
MKS (MKSI) – Investment Analysts’ Recent Ratings Changes
Several analysts have recently updated their ratings and price targets for MKS (NASDAQ: MKSI): 8/8/2026 – MKS was upgraded by Wall Street Zen from “buy” to “strong-buy”. 8/7/2026 – MKS had its price target raised by Citigroup Inc. from $425.00 to $430.00. They now have a “buy” rating on the stock. 8/7/2026 – MKS had […]
Weekly Research Analysts’ Ratings Updates for uniQure (QURE)
Several analysts have recently updated their ratings and price targets for uniQure (NASDAQ: QURE): 8/1/2026 – uniQure was downgraded by Wall Street Zen from “hold” to “sell”. 7/30/2026 – uniQure had its price target lowered by Barclays PLC from $65.00 to $60.00. They now have an “overweight” rating on the stock. 7/30/2026 – uniQure had […]
Icon (ICLR) – Research Analysts’ Recent Ratings Changes
Several analysts have recently updated their ratings and price targets for Icon (NASDAQ: ICLR): 7/31/2026 – Icon was given a new $194.00 price target by Robert W. Baird. 7/31/2026 – Icon had its price target raised by Citigroup Inc. from $165.00 to $180.00. They now have a “neutral” rating on the stock. 7/31/2026 – Icon […]
Research Analysts’ Recent Ratings Updates for IDACORP (IDA)
A number of research firms have changed their ratings and price targets for IDACORP (NYSE: IDA): 8/3/2026 – IDACORP had its “buy (b)” rating reaffirmed by Weiss Ratings. 8/3/2026 – IDACORP had its price target lowered by Barclays PLC from $167.00 to $162.00. They now have an “overweight” rating on the stock. 8/2/2026 – IDACORP […]
Teradata (TDC) – Research Analysts’ Weekly Ratings Changes
Teradata (NYSE: TDC) recently received a number of ratings updates from brokerages and research firms: 8/10/2026 – Teradata had its “equal weight” rating reaffirmed by Morgan Stanley. They now have a $29.00 price target on the stock, down from $35.00. 8/8/2026 – Teradata was downgraded by Wall Street Zen from “strong-buy” to “hold”. 8/6/2026 – […]
Weekly Research Analysts’ Ratings Updates for Infosys (INFY)
Several analysts have recently updated their ratings and price targets for Infosys (NYSE: INFY): 7/28/2026 – Infosys was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”. 7/24/2026 – Infosys had its “market perform” rating reaffirmed by BMO Capital Markets. They now have a $12.00 price target on the stock, down from $13.00. 7/24/2026 […]
Steven Madden (SHOO) – Investment Analysts’ Recent Ratings Changes
Steven Madden (NASDAQ: SHOO) has recently received a number of price target changes and ratings updates: 8/8/2026 – Steven Madden was upgraded by Wall Street Zen from “buy” to “strong-buy”. 8/5/2026 – Steven Madden was given a new $55.00 price target by Piper Sandler. They now have an “overweight” rating on the stock. 8/4/2026 – […]
WesBanco (WSBC) – Investment Analysts’ Recent Ratings Updates
WesBanco (NASDAQ: WSBC) has recently received a number of price target changes and ratings updates: 8/3/2026 – WesBanco had its “buy (b)” rating reaffirmed by Weiss Ratings. 8/1/2026 – WesBanco was downgraded by Wall Street Zen from “hold” to “sell”. 7/23/2026 – WesBanco had its price target raised by Royal Bank Of Canada from $41.00 […]
Investment Analysts’ Weekly Ratings Updates for Redwire (RDW)
A number of research firms have changed their ratings and price targets for Redwire (NYSE: RDW): 8/10/2026 – Redwire had its price target raised by Canaccord Genuity Group Inc. from $14.00 to $15.00. They now have a “buy” rating on the stock. 8/9/2026 – Redwire was given a new $15.00 price target by Jefferies Financial […]
Weekly Research Analysts’ Ratings Updates for EastGroup Properties (EGP)
Several brokerages have updated their recommendations and price targets on shares of EastGroup Properties (NYSE: EGP) in the last few weeks: 8/3/2026 – EastGroup Properties had its price target raised by Royal Bank Of Canada from $208.00 to $220.00. They now have a “sector perform” rating on the stock. 7/31/2026 – EastGroup Properties was given […]
Analysts’ Recent Ratings Updates for Travis Perkins (TPK)
A number of research firms have changed their ratings and price targets for Travis Perkins (LON: TPK): 8/7/2026 – Travis Perkins had its price target raised by JPMorgan Chase & Co. from GBX 630 to GBX 710. They now have an “overweight” rating on the stock. 8/5/2026 – Travis Perkins had its price target raised […]
Encore Capital Group (ECPG) – Research Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Encore Capital Group (NASDAQ: ECPG): 8/11/2026 – Encore Capital Group had its “market outperform” rating reaffirmed by Citigroup Inc.. 8/7/2026 – Encore Capital Group was upgraded by Zacks Research from “hold” to “strong-buy”. 8/6/2026 – Encore Capital Group had its price target […]
Investment Analysts’ Weekly Ratings Changes for Royalty Pharma (RPRX)
Royalty Pharma (NASDAQ: RPRX) recently received a number of ratings updates from brokerages and research firms: 8/8/2026 – Royalty Pharma was downgraded by Wall Street Zen from “strong-buy” to “buy”. 8/7/2026 – Royalty Pharma had its price target raised by JPMorgan Chase & Co. from $58.00 to $62.00. They now have an “overweight” rating on […]
Research Analysts’ Weekly Ratings Updates for Churchill Downs (CHDN)
A number of firms have modified their ratings and price targets on shares of Churchill Downs (NASDAQ: CHDN) recently: 8/3/2026 – Churchill Downs had its price target raised by Mizuho from $155.00 to $157.00. They now have an “outperform” rating on the stock. 7/31/2026 – Churchill Downs had its “sell (d+)” rating reaffirmed by Weiss […]
Chemed (CHE) – Investment Analysts’ Recent Ratings Changes
Chemed (NYSE: CHE) recently received a number of ratings updates from brokerages and research firms: 8/1/2026 – Chemed was upgraded by Wall Street Zen from “hold” to “strong-buy”. 7/31/2026 – Chemed had its price target raised by Oppenheimer Holdings, Inc. from $500.00 to $590.00. They now have an “outperform” rating on the stock. 7/30/2026 – […]
Weekly Research Analysts’ Ratings Updates for Cirrus Logic (CRUS)
Cirrus Logic (NASDAQ: CRUS) recently received a number of ratings updates from brokerages and research firms: 8/8/2026 – Cirrus Logic was downgraded by Wall Street Zen from “buy” to “hold”. 8/6/2026 – Cirrus Logic had its price target lowered by Stifel Nicolaus from $197.00 to $160.00. They now have a “buy” rating on the stock. […]
Research Analysts’ Recent Ratings Updates for Quaker Houghton (KWR)
A number of firms have modified their ratings and price targets on shares of Quaker Houghton (NYSE: KWR) recently: 8/6/2026 – Quaker Houghton was upgraded by Zacks Research from “hold” to “strong-buy”. 8/3/2026 – Quaker Houghton was upgraded by Weiss Ratings from “sell (d+)” to “hold (c)”. 8/3/2026 – Quaker Houghton had its price target […]
Investment Analysts’ Recent Ratings Changes for Shoulder Innovations (SI)
A number of research firms have changed their ratings and price targets for Shoulder Innovations (NYSE: SI): 8/10/2026 – Shoulder Innovations had its price target raised by UBS Group AG from $27.00 to $28.00. They now have a “buy” rating on the stock. 8/7/2026 – Shoulder Innovations had its “overweight” rating reaffirmed by Piper Sandler. […]
Investment Analysts’ Weekly Ratings Changes for Canadian Pacific Kansas City (CP)
A number of research firms have changed their ratings and price targets for Canadian Pacific Kansas City (TSE: CP): 7/30/2026 – Canadian Pacific Kansas City had its price target raised by BMO Capital Markets from C$142.00 to C$145.00. They now have an “outperform” rating on the stock. 7/30/2026 – Canadian Pacific Kansas City had its […]
Rocky Brands (RCKY) – Research Analysts’ Recent Ratings Changes
A number of research firms have changed their ratings and price targets for Rocky Brands (NASDAQ: RCKY): 8/9/2026 – Rocky Brands was upgraded by Wall Street Zen from “buy” to “strong-buy”. 8/6/2026 – Rocky Brands was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”. 8/1/2026 – Rocky Brands was upgraded by Wall Street […]
Hudbay Minerals (HBM) – Research Analysts’ Weekly Ratings Changes
Hudbay Minerals (TSE: HBM) recently received a number of ratings updates from brokerages and research firms: 7/30/2026 – Hudbay Minerals had its price target lowered by Scotiabank from C$44.00 to C$43.00. They now have a “sector outperform” rating on the stock. 7/30/2026 – Hudbay Minerals had its price target lowered by ATB Cormark Capital Markets […]
Research Analysts’ Recent Ratings Updates for Surgery Partners (SGRY)
A number of research firms have changed their ratings and price targets for Surgery Partners (NASDAQ: SGRY): 8/11/2026 – Surgery Partners was given a new $18.00 price target by Raymond James Financial, Inc.. 8/11/2026 – Surgery Partners had its “buy” rating reaffirmed by Benchmark Co.. 8/11/2026 – Surgery Partners had its “buy” rating reaffirmed by […]
last updated on 12 Aug 10:58